Maximizing Discovery & Innovation While Minimizing Cost — Contract Pharma

In this Contract Pharma interview, I discussed how our operational model allows research teams to achieve enterprise-grade capability without capital expense or delay. The conversation focused on practical efficiency — designing labs that scientists can use immediately, with compliance, logistics, and services already built in.

It also examined how the managed-infrastructure approach helps large pharma and startups collaborate more effectively, sharing data and facilities while maintaining full independence.

Read the full article → Contract Pharma